About Smith & Nephew plc (LON:SN)
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Devices & Implants
- Sub-Industry: N/A
- Symbol: LON:SN
- CUSIP: N/A
- Web: www.smith-nephew.com/
- Market Cap: £12.5 billion
- Outstanding Shares: 875,675,000
- 50 Day Moving Avg: GBX 1,372.70
- 200 Day Moving Avg: GBX 1,334.35
- 52 Week Range: GBX 1,064.91 - GBX 1,442
Sales & Book Value:
- Trailing P/E Ratio: 14.61
- P/E Growth: 0.00
- Annual Revenue: £4.68 billion
- Price / Sales: 2.67
- Book Value: GBX 4.80 per share
- Price / Book: 2.98
- EBITDA: £1.32 billion
- Net Margins: 13.87%
- Return on Equity: 15.84%
- Return on Assets: 8.74%
- Average Volume: 3.43 million shs.
Frequently Asked Questions for Smith & Nephew plc (LON:SN)
What is Smith & Nephew plc's stock symbol?
Smith & Nephew plc trades on the London Stock Exchange (LON) under the ticker symbol "SN."
How often does Smith & Nephew plc pay dividends? What is the dividend yield for Smith & Nephew plc?
Smith & Nephew plc declared a dividend on Thursday, July 27th. Stockholders of record on Thursday, October 5th will be given a dividend of GBX 0.12 per share on Wednesday, November 1st. This represents a dividend yield of 0.72%. The ex-dividend date is Thursday, October 5th. The official announcement can be viewed at this link. View Smith & Nephew plc's Dividend History.
Where is Smith & Nephew plc's stock going? Where will Smith & Nephew plc's stock price be in 2017?
11 brokers have issued 12 month target prices for Smith & Nephew plc's stock. Their predictions range from GBX 1,144 to GBX 1,515. On average, they expect Smith & Nephew plc's stock price to reach GBX 1,302.91 in the next year. View Analyst Ratings for Smith & Nephew plc.
Who are some of Smith & Nephew plc's key competitors?
Some companies that are related to Smith & Nephew plc include Smith & Nephew SNATS (SNN), Glaukos Corporation (GKOS), Endologix (ELGX), Cerus Corporation (CERS), RTI Surgical (RTIX), ConforMIS (CFMS), Obalon Therptcs (OBLN), Second Sight Medical Products (EYES), Concepta PLC (CPT), Concepta PLC (FRI), Cyberonics (CYBX), HeartWare International (HTWR), St Jude Medical (STJ), Trivascular Technologies (TRIV) and Uroplasty (UPI).
Who are Smith & Nephew plc's key executives?
Smith & Nephew plc's management team includes the folowing people:
- Olivier Bohuon, Chief Executive Officer, Executive Director
- Graham Baker, Chief Financial Officer, Executive Director
- Rodrigo Bianchi, President, Asia Pacific and Emerging Markets
- Brad Cannon, President, Europe and Canada
- Vasant Padmanabhan Ph.D., President - Research & Development
- Cyrille Petit, Chief Corporate Development Officer, President - Global Business Services
- Matthew R. Stober, President - Global Operations
- Glenn S. Warner, President, US
- Elga Lohler, Chief Human Resource Officer
- John W. Campo, Chief Legal Officer
How do I buy Smith & Nephew plc stock?
Shares of Smith & Nephew plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Smith & Nephew plc's stock price today?
MarketBeat Community Rating for Smith & Nephew plc (LON SN)MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Smith & Nephew plc stock can currently be purchased for approximately GBX 1,428.
Consensus Ratings for Smith & Nephew plc (LON:SN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 7 Hold Ratings, 3 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.18)|
|Consensus Price Target: ||GBX 1,302.91|Consensus Price Target History for Smith & Nephew plc (LON:SN)
Analysts' Ratings History for Smith & Nephew plc (LON:SN)
(Data available from 10/21/2015 forward)
|10/19/2017||J P Morgan Chase & Co||Boost Price Target||Neutral||GBX 1,361 -> GBX 1,382|
|10/13/2017||Deutsche Bank AG||Reiterated Rating||Buy|
|10/12/2017||Jefferies Group LLC||Reiterated Rating||Buy||GBX 1,515|
|10/12/2017||Citigroup Inc.||Reiterated Rating||Sell||GBX 1,160|
|9/11/2017||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Neutral||GBX 1,380|
|7/28/2017||Credit Suisse Group||Reiterated Rating||Neutral||GBX 1,280|
|7/18/2017||Berenberg Bank||Reiterated Rating||Hold||GBX 1,300|
|7/10/2017||HSBC Holdings plc||Reiterated Rating||Hold||GBX 1,320|
|5/15/2017||Morgan Stanley||Reiterated Rating||Overweight|
|5/5/2017||Numis Securities Ltd||Reiterated Rating||Add||GBX 1,350|
|5/5/2017||Shore Capital||Reiterated Rating||Hold||GBX 1,144|
|8/10/2016||Barclays PLC||Downgrade||Equal weight||GBX 1,230 -> GBX 1,240|
|8/9/2016||Beaufort Securities||Reiterated Rating||Hold|
|7/29/2016||BNP Paribas||Reiterated Rating||Outperform||GBX 1,425|
|3/17/2016||Nomura||Initiated Coverage||Neutral||GBX 1,215|
|3/10/2016||AlphaValue||Reiterated Rating||Add||GBX 1,389|
|2/9/2016||Sanford C. Bernstein||Reiterated Rating||Outperform||GBX 1,340|
Earnings History for Smith & Nephew plc (LON:SN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Smith & Nephew plc (LON:SN)
Current Year EPS Consensus Estimate: $0.85 EPS
Dividend History by Quarter for Smith & Nephew plc (LON SN)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Smith & Nephew plc (LON:SN)Insider Trades by Quarter for Smith & Nephew plc (LON:SN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/16/2017||Virginia Bottomley||Insider||Buy||223||GBX 1,380||£3,077.40|
|3/9/2017||Olivier Bohuon||Insider||Sell||6,273||GBX 1,233||£77,346.09|
|3/7/2017||Olivier Bohuon||Insider||Sell||8,031||GBX 1,222||£98,138.82|
|8/15/2016||Bottomley ,Virginia||Insider||Buy||238||GBX 1,290||£3,070.20|
|5/11/2016||Bottomley ,Virginia||Insider||Buy||8||GBX 1,158||GBX 9,264|
|8/14/2015||Barlow ,Ian||Insider||Buy||153||GBX 1,188||£1,817.64|
|5/13/2015||Vinita Bali||Insider||Buy||2,400||GBX 1,118||£26,832|
|3/9/2015||Julie Brown||Insider||Sell||4,227||GBX 1,128.79||£47,713.95|
|2/5/2015||Julie Brown||Insider||Sell||11,789||GBX 1,181||£139,228.09|
Headline Trends for Smith & Nephew plc (LON:SN)
Latest Headlines for Smith & Nephew plc (LON:SN)
Smith & Nephew plc (SN) Chart for Saturday, October, 21, 2017